Asia Pacific Amniocentesis Needle Market Size, Share & Trends Analysis Report By Procedure, By End-use, By Type (100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm), By Country and Growth Forecast, 2023 - 2030

The Asia Pacific Amniocentesis Needle Market would witness market growth of 7.3% CAGR during the forecast period (2023-2030).

The amniocentesis needle market is witnessing expansion and increased accessibility, driven by greater awareness of prenatal diagnostic options, improved healthcare infrastructure, and expanding healthcare coverage in emerging markets. Efforts to reduce healthcare disparities and increase access to prenatal care are facilitating the adoption of amniocentesis procedures in regions with previously limited access to advanced prenatal diagnostics.

Integrating AI and machine learning algorithms into imaging systems and needle guidance platforms will enable automated needle placement, real-time image analysis, and predictive modeling to optimize procedural outcomes and enhance diagnostic accuracy. AI-driven decision support tools will assist healthcare providers in interpreting complex imaging data and identifying subtle anatomical landmarks during amniocentesis procedures.

China's growing medical device sector allows manufacturers and suppliers of amniocentesis needles to expand their regional presence. As per the International Trade Administration (ITA), the medical device industry in China is expected to expand between 2021-2026 at a rate of 8.3%, bringing it to $48.8 billion by 2026. Furthermore, the projected growth of the medical device industry in China creates opportunities for the amniocentesis needle market, influencing demand patterns, market dynamics, technological innovation, regulatory considerations, and competitive landscapes. Therefore, the growing medical device industry in the region is driving the market's growth.

The China market dominated the Asia Pacific Amniocentesis Needle Market, by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $22610.9 Million by 2030. The Japan market is registering a CAGR of 6.6% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 7.9% during (2023 - 2030).

Based on Procedure, the market is segmented into Amniocentesis Procedures, Fetal Blood Transfusion, Amnioreduction Procedures, Amnioinfusion Procedure, and Cordocentesis Procedure. Based on End-use, the market is segmented into Hospitals, Diagnostics centers, Clinics, and Others. Based on Type, the market is segmented into 100 to 150 mm, Larger Than 150 mm, and Smaller Than 100 mm. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

List of Key Companies Profiled

• BIOPSYBELL S.R.L.
• Cook Medical, Inc. (Cook Group)
• Ri.Mos. Srl
• CooperSurgical, Inc. (The Cooper Companies, Inc.)
• Rocket Medical plc (Röko AB)
• Argon Medical Devices, Inc. (SHANDONG WEIGAO GROUP MEDICAL POLYMER COMPANY LIMITED)
• Moller Medical GmbH (Centrotec SE)
• Becton, Dickinson and Company

Market Report Segmentation

By Procedure

• Amniocentesis Procedures
• Fetal Blood Transfusion
• Amnioreduction Procedures
• Amnioinfusion Procedure
• Cordocentesis Procedure

By End-use

• Hospitals
• Diagnostics centers
• Clinics
• Others

By Type

• 100 to 150 mm
• Larger Than 150 mm
• Smaller Than 100 mm

By Country

• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific